Brooks Laboratories Q4 Results

  • BSE: 533543
  • NSE: BROOKS
  • ISIN: INE650L01011
  • Sector: Major Drugs
BSE
143.82.80 (1.99%)
Volume9.84 K
Updated: Mon 25 Nov, 2024 | 15:15:00
NSE
142.82.80 (2.00%)
Volume17.09 K
Updated: Mon 25 Nov, 2024 | 15:15:10
Today: 138.50
143.80
52-Wk: 72.51
185.15

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Brooks Laboratories Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 17.7215.30-%12.70-%
    Selling/ General/ Admin Expenses Total 2.284.14-%2.26-%
    Depreciation/ Amortization 0.462.33-%0.44-%
    Other Operating Expenses Total 2.358.21-%2.27-%
    Total Operating Expense 17.8025.83-%13.17-%
    Operating Income -0.08-10.53-%-0.48-%
    Net Income Before Taxes -9.61-11.18-%-4.30-%
    Net Income -9.61-5.02-%-4.30-%
    Diluted Normalized EPS -3.77-2.10-%-1.71-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts